Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Genovate Biotechnology CoROCO:4130 +2.61%73 Days Inventory is 170.60 as of Dec. 2025, which is 3% above its 10-year median of 165.85. GuruFocus rates ROCO:4130 with a GF Score™ of 73/100 and a GF Value™ of NT$22.20 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 638 Biotechnology companies, Genovate Biotechnology Co ranks better than 55.02% on this metric.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Genovate Biotechnology Co's Inventory Turnover for the
three
months ended in Dec. 2025 was 0.53.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genovate Biotechnology Co's Inventory-to-Revenue for the
three
months ended in Dec. 2025 was 1.23.
Genovate Biotechnology Co (ROCO:4130) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Genovate Biotechnology Co's Inventory Turnover for the
three
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genovate Biotechnology Co's Inventory to Revenue for the
three
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Genovate Biotechnology Co Days Inventory Related Terms
Genovate Biotechnology Co Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:4130 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Genovate Biotechnology Co's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genovate Biotechnology Co Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genovate Biotechnology Co's Days Inventory distribution charts can be found below:
* The bar in red indicates where Genovate Biotechnology Co's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genovate Biotechnology Co (ROCO:4130) has a Days Inventory of 170.60 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genovate Biotechnology Co and its competitors. This is near median its historical median of 165.85. Over the past decade, Genovate Biotechnology Co's Days Inventory has ranged from 147.81 to 183.73. According to the industry distribution chart, Genovate Biotechnology Co ranks #287 out of 638 companies in the Biotechnology industry, placing it in the top 45%.
Is Genovate Biotechnology Co's Days Inventory too high?
Genovate Biotechnology Co's current Days Inventory of 170.60 is near median its 10-year median of 165.85. Over the past 10 years, this metric has ranged from a low of 147.81 to a high of 183.73. The Biotechnology industry median Days Inventory is 183.20. Genovate Biotechnology Co's value of 170.60 is 6.9% below this industry median. Based on the distribution chart, Genovate Biotechnology Co ranks #287 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Genovate Biotechnology Co has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Genovate Biotechnology Co's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genovate Biotechnology Co ranks #287 out of 638 companies for Days Inventory. This puts Genovate Biotechnology Co in the upper half of its industry. The industry median Days Inventory is 183.20. Genovate Biotechnology Co's value of 170.60 is 6.9% below this benchmark. Historically, Genovate Biotechnology Co's own Days Inventory has ranged from 147.81 to 183.73 over the past decade. While the company's 10-year median is 165.85 vs. the industry median of 183.20, Genovate Biotechnology Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genovate Biotechnology Co's current Days Inventory of 170.60 is 6.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genovate Biotechnology Co and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genovate Biotechnology Co's current Days Inventory is 170.60, which is near median its own 10-year median of 165.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genovate Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Genovate Biotechnology Co (ROCO:4130) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$22.20, compared to a current price of NT$27.55 — trading 24.1% above its estimated fair value. The current Days Inventory is 170.60, which is near median its 10-year median of 165.85 and 6.9% below the Biotechnology industry median of 183.20. Genovate Biotechnology Co's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Genovate Biotechnology Co (ROCO:4130), the current Days Inventory is 170.60 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genovate Biotechnology Co (ROCO:4130) Overvalued in 2026?
Based on GuruFocus' analysis, Genovate Biotechnology Co stock appears to be overvalued.
The current stock price of NT$27.55 is trading 24.1% above its estimated GF Value™ of NT$22.20.
GuruFocus considers Genovate Biotechnology Co to be Modestly Overvalued.
Key valuation signals for ROCO:4130:
Days Inventory: 170.60 (near median its 10-year median of 165.85)
GF Value™: NT$22.20 vs. price of NT$27.55 (24.1% above fair value)
Industry Position: 6.9% below the Biotechnology median (#287 of 638)
No single metric tells the full story. See the ROCO:4130 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Genovate Biotechnology Co Ltd develops, produces, manufactures, and sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria, and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases, etc. The company is also engaged in the sales of medicines for the prevention and treatment of diseases caused by viruses and bacteria, and medicines for the treatment of cardiovascular, gastrointestinal, cancer, and autoimmune diseases etc.
73GF Score
Get the complete analysis for ROCO:4130
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:4130 has been successfully added to your 
